Efficacy and Safety of Ixekizumab in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study in Paediatric Patients with Moderate‐to‐Severe Plaque Psoriasis (IXORA‐PEDS)
Efficacy and Safety of Ixekizumab in a Phase 3, Randomized, Double‐Blind, Placebo‐Controlled Study in Paediatric Patients with Moderate‐to‐Severe Plaque Psoriasis (IXORA‐PEDS)
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started